On 25 January, Lonza Bioscience Informatics and NNIT will host a free 60-minute webinar to discuss the key requirements of next generation Manufacturing Execution Systems (MES) and how small- and medium-sized companies can overcome critical implementation challenges for accelerated pharma digitalization. Webinar attendees will also have the chance to engage with the expert presenters in a live Q&A session following the webinar.
As digital transformation of pharmaceutical manufacturing becomes critical for companies to ensure compliance and remain competitive, the requirement for a more agile and accelerated approach to implementation of MES is becoming clear. However, MES implementation projects have traditionally been viewed as complex, time and resource intensive, and inaccessible to smaller organizations. In the case of cell and gene therapy (CGT) manufacturing, available systems often need extensive customization to accommodate inherent workflow complexities, further complicating deployment.
“Achieving Pharma 4.0 through Accelerated MES Implementation Discover how implementation of next-generation Manufacturing Execution Systems (MES) can be optimized and streamlined to pave the way to faster pharma digitalization“
Lonza has extensive first-hand experience of the challenges facing organizations that have their sights on achieving pharma 4.0. NNIT has more than 15 years of experience in digital transformation for the pharmaceutical manufacturing and supply chain space, developing the renowned NNIT Accelerated Implementation Methodology for expedited MES deployment. In March 2021, the two companies partnered in a bid to overcome the time-consuming and costly nature of MES implementation across the industry.
PR Account Manager | BioStrata Ltd
T: +44 (0)1223 627138
E: email@example.comSee all the latest jobs in Pharmaceutical